Influenza

>

Latest News

High-Dose Influenza Vaccine vs Standard Dose: Hospitalization Outcomes in Older Adults
High-Dose Influenza Vaccine vs Standard Dose: Hospitalization Outcomes in Older Adults

August 30th 2025

A Danish trial of 330,000+ adults ≥65 found high and standard-dose influenza vaccines had similar effectiveness against influenza or pneumonia-related hospitalizations.

 RFK, HHS OKs Removal of Thimerosal From Influenza Vaccines
RFK, HHS OKs Removal of Thimerosal From Influenza Vaccines

July 24th 2025

Moderna’s mRNA-1010 Shows Efficacy in Phase 3 Seasonal Flu Vaccine Trial
Moderna’s mRNA-1010 Shows Efficacy in Phase 3 Seasonal Flu Vaccine Trial

July 1st 2025

Novavax Reports Immune Responses and Safety in Phase 3 Trial of COVID-19-Influenza Combination Vaccine
Novavax Reports Immune Responses and Safety in Phase 3 Trial of COVID-19-Influenza Combination Vaccine

June 12th 2025

Nationwide Avian Flu Response Gains Momentum, Yet Urgent Action Remains Essential
Nationwide Avian Flu Response Gains Momentum, Yet Urgent Action Remains Essential

June 11th 2025

More News

© 2025 MJH Life Sciences

All rights reserved.